Regaining compliance with Nasdaq's minimum bid price requirement is a significant positive development for Gossamer Bio. It removes the immediate risk of delisting, which can be a major concern for investors and can negatively impact stock price and company reputation. This news is likely to be viewed positively by the market, potentially leading to an increase in investor confidence and a positive impact on the stock price in the short term.